Skip to main content
Fig. 3 | Clinical and Translational Allergy

Fig. 3

From: Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial

Fig. 3

Birch pollen-specific IgE, IgG1 and IgG4 concentrations. Median values with 25th/75th and 10th/90th percentiles represented by boxes and error bars respectively, outliers by points. Time points: 1, screening before SCIT; 2, after up-dosing first year; 3, after pollen season first year; 4, after up-dosing second year; and 5, after pollen season second year

Back to article page

Clinical and Translational Allergy

ISSN: 2045-7022

Contact us